N-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)quinolin-4-amine | 133671-49-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)quinolin-4-amine
• 英文别名: 1,2-Ethanediamine, N'-(2-(4-methoxyphenyl)-4-quinolinyl)-N,N-dimethyl-；N-[2-(4-methoxyphenyl)quinolin-4-yl]-N',N'-dimethylethane-1,2-diamine
• CAS: 133671-49-5
• 化学式: C₂₀H₂₃N₃O
• 分子量: 321.422
• InChiKey: DPIXUMPQZPSUKL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  37.4
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  N-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)quinolin-4-amine 在 三溴化硼 作用下， 生成 4-[4-(2-Dimethylamino-ethylamino)-quinolin-2-yl]-2,6-bis-(4-methyl-piperazin-1-ylmethyl)-phenol
  参考文献：
  名称：

  新的三螺旋DNA稳定剂。

  摘要：

  合成了几种取代的喹啉-4-胺和杂芳族类似物，并通过紫外-热熔融实验评估了其与三链体polydA.2polydT和双链体polydA.polydT的相互作用。通过合理的方法设计了对TAT三联体具有高亲和力和三重/双重选择性的优秀三重螺旋DNA配体。

  DOI：

  10.1016/j.bmcl.2004.12.019
• 作为产物：
  描述：

  邻氨基三氟甲苯 在 正丁基锂 、 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 反应 11.08h， 生成 N-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)quinolin-4-amine
  参考文献：
  名称：

  Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents

  摘要：

  Thirty-eight 2-(aryl or heteroaryl)quinolin-4-amines, N,N-disubstituted, N-monosubstituted, and without a substituent at the amino group have been synthesized with use of novel chemistries developed by us recently. Some of these derivatives show anti-HIV-1 activity at a concentration level of 1-mu-M and low cell toxicity in vitro. The most active and least toxic compounds are derivatives of 2-(3-pyridyl)quinoline. The results of the quantitative structure-activity relationship analyses, including several classical, linear regression correlations and a Free-Wilson approach, of de novo model, provide guidelines for the design of new active compounds of this class.

  DOI：

  10.1021/jm00109a031

文献信息

• STREKOWSKI, LUCJAN;MOKROSZ, JERZY L.;HONKAN, VIDYA A.;CZARNY, AGNIESZKA;C+, J. MED. CHEM., 34,(1991) N, C. 1739-1746
  作者：STREKOWSKI, LUCJAN、MOKROSZ, JERZY L.、HONKAN, VIDYA A.、CZARNY, AGNIESZKA、C+

  DOI：——

  日期：——
• MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS
  申请人：Biohaven Therapeutics Ltd.

  公开号：US20220388962A1

  公开（公告）日：2022-12-08

  Pharmaceutical compositions of the invention comprise TDP-43 binding agents having a disease-modifying action in the treatment of diseases associated with TDP-43 that include ALS, FTLD, CTE, hippocampal sclerosis of aging (CARTS), Alzheimer's disease, and Alzheimer's disease related disorder, and disease that involve excess amounts of TDP-43 in the cytosol.
• [EN] MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS<br/>[FR] MOLÉCULES QUI SE LIENT À TDP-43 POUR LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE ET DE TROUBLES APPARENTÉS
  申请人：BIOHAVEN THERAPEUTICS LTD

  公开号：WO2021035101A1

  公开（公告）日：2021-02-25

  Pharmaceutical compositions of the invention comprise TDP-43 binding agents having a disease-modifying action in the treatment of diseases associated with TDP-43 that include ALS, FTLD, CTE, hippocampal sclerosis of aging (CARTS), Alzheimers disease, and Alzheimers disease related disorder, and disease that involve excess amounts of TDP-43 in the cytosol.